Journal article · 2025 · Open access
CAR-T cells in B-cell mediated autoimmune diseases: do all roads lead to Rome?
Cell and Gene Therapy Insights, 11(1), 141–148 · Published 13 February 2025 · DOI 10.18609/cgti.2025.018
In brief
“CAR-T cells in B-cell mediated autoimmune diseases: do all roads lead to Rome?” is a 2025 journal article by Dimitrios Mougiakakos, published in Cell and Gene Therapy Insights. OpenAlex counts 0 citations as of 19 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at Cell and Gene Therapy Insights.
- Citations
- 0
- Authors
- 1
Abstract
The use of CAR-T cell therapies in autoimmune diseases represents a groundbreaking shift in treatment paradigms. Building on successes in hematologic oncology, CAR-T cells targeting CD19 have shown profound efficacy in achieving durable remissions, as exemplified by the first patient treated for severe systemic lupus erythematosus. These therapies offer advantages such as active migration of a ‘living’ drug, deep tissue penetration, and potential immunologic reset over traditional B-cell depleting strategies. Complementary approaches, including bispecific antibodies and emerging cell-based modalities such as allogeneic CAR-T cells or CAR NK cells, are expanding the therapeutic armamentarium. While promising, challenges remain with respect to scalability, accessibility, and long-term outcomes. Ongoing research heralds a paradigm shift in personalized, durable autoimmune therapies. Road(s) to Rome: T cell-mediated B-cell depletion as a promising therapeutic approach for B-cell-driven autoimmune diseases. Currently, different strategies are being explored for clinical implementation: the use of established CAR-T cells, well known from real-world experience in hematology and oncology; novel CAR technologies originally developed for hematologic malignancies, now being directly evaluated in autoimmune diseases; and T cell engagers, which enable targeted immune modulation without the need for cell transfer. All these approaches share the common goal of effectively addressing the challenges in the treatment of autoimmune diseases.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Mougiakakos, D. (2025). CAR-T cells in B-cell mediated autoimmune diseases: do all roads lead to Rome? Cell and Gene Therapy Insights, 11(1), 141–148. https://doi.org/10.18609/cgti.2025.018
MLA 9
Mougiakakos, Dimitrios. “CAR-T cells in B-cell mediated autoimmune diseases: do all roads lead to Rome?” Cell and Gene Therapy Insights, vol. 11, no. 1, 2025, pp. 141–148. https://doi.org/10.18609/cgti.2025.018.
Chicago
Mougiakakos, Dimitrios. 2025. “CAR-T cells in B-cell mediated autoimmune diseases: do all roads lead to Rome?” Cell and Gene Therapy Insights 11 (1): 141–148. https://doi.org/10.18609/cgti.2025.018.
Harvard
Mougiakakos, D. (2025) ‘CAR-T cells in B-cell mediated autoimmune diseases: do all roads lead to Rome?’, Cell and Gene Therapy Insights, 11(1), pp. 141–148. doi:10.18609/cgti.2025.018.
IEEE
D. Mougiakakos, “CAR-T cells in B-cell mediated autoimmune diseases: do all roads lead to Rome?,” Cell and Gene Therapy Insights, vol. 11, no. 1, pp. 141–148, 2025, doi: 10.18609/cgti.2025.018.
BibTeX
@article{mougiakakos2025cells,
title = {{CAR-T cells in B-cell mediated autoimmune diseases: do all roads lead to Rome?}},
author = {Mougiakakos, Dimitrios},
journal = {Cell and Gene Therapy Insights},
year = {2025},
volume = {11},
number = {1},
pages = {141–148},
doi = {10.18609/cgti.2025.018},
url = {https://doi.org/10.18609/cgti.2025.018}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- chimeric antigen receptor T cells
- CD19
- systemic lupus erythematosus
- B-cell depletion
- bispecific antibodies
- allogeneic CAR T cells
- CAR-NK cells
- T-cell engagers
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Mougiakakos, D. (2025). CAR-T cells in B-cell mediated autoimmune diseases: do all roads lead to Rome? Cell and Gene Therapy Insights, 11(1), 141–148. https://doi.org/10.18609/cgti.2025.018
How many times has this paper been cited?
0 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Cell and Gene Therapy Insights: sign in and open the full text from this page.
Who wrote this paper?
Dimitrios Mougiakakos.
What is the DOI of this paper?
10.18609/cgti.2025.018, permanently at https://doi.org/10.18609/cgti.2025.018. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.